{"abstract": "Pfizer said that it had licensed the worldwide rights to a treatment for Gaucher disease, a genetic disorder, putting Pfizer into competition with Genzyme.", "web_url": "https://www.nytimes.com/2009/12/02/business/02drug.html", "snippet": "Pfizer said that it had licensed the worldwide rights to a treatment for Gaucher disease, a genetic disorder, putting Pfizer into competition with Genzyme.", "lead_paragraph": "The world\u2019s largest drug company is thinking small. ", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Deal Signals a Move Into Treating Rare Diseases", "kicker": null, "content_kicker": null, "print_headline": "Pfizer Deal Signals a Move Into Treating Rare Diseases", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}, {"name": "subject", "value": "Gaucher's Disease", "rank": 4, "major": "N"}], "pub_date": "2009-12-01T12:05:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/39cdcd29-84bb-5035-8d10-97a1e977c911", "word_count": 703, "uri": "nyt://article/39cdcd29-84bb-5035-8d10-97a1e977c911"}